Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
2
Department of Pharmacology
3
School of Medicine
5
Thessaloniki, Greece
|
Publication type: Journal Article
Publication date: 2020-04-01
scimago Q1
wos Q1
SJR: 6.788
CiteScore: 53.2
Impact factor: 32.8
ISSN: 22132600, 22132619
PubMed ID:
32171062
Pulmonary and Respiratory Medicine
Abstract
The most distinctive comorbidities of 32 non-survivors from a group of 52 intensive care unit patients with novel coronavirus disease 2019 (COVID-19) in the study by Xiaobo Yang and colleagues1 were cerebrovascular diseases (22%) and diabetes (22%). Another study2 included 1099 patients with confirmed COVID-19, of whom 173 had severe disease with comorbidities of hypertension (23·7%), diabetes mellitus (16·2%), coronary heart diseases (5·8%), and cerebrovascular disease (2·3%). In a third study,3 of 140 patients who were admitted to hospital with COVID-19, 30% had hypertension and 12% had diabetes.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
30
|
|
|
PLoS ONE
28 publications, 1.38%
|
|
|
Frontiers in Immunology
26 publications, 1.29%
|
|
|
Journal of Clinical Medicine
24 publications, 1.19%
|
|
|
Scientific Reports
21 publications, 1.04%
|
|
|
Cureus
19 publications, 0.94%
|
|
|
Frontiers in Pharmacology
19 publications, 0.94%
|
|
|
International Journal of Molecular Sciences
17 publications, 0.84%
|
|
|
Diabetes and Metabolic Syndrome: Clinical Research and Reviews
17 publications, 0.84%
|
|
|
Diabetes Research and Clinical Practice
17 publications, 0.84%
|
|
|
Frontiers in Public Health
16 publications, 0.79%
|
|
|
Frontiers in Medicine
16 publications, 0.79%
|
|
|
BMJ Open
14 publications, 0.69%
|
|
|
International Journal of Environmental Research and Public Health
13 publications, 0.64%
|
|
|
Journal of Hypertension
11 publications, 0.54%
|
|
|
Journal of Medical Virology
11 publications, 0.54%
|
|
|
medRxiv : the preprint server for health sciences
11 publications, 0.54%
|
|
|
Medicine (United States)
10 publications, 0.49%
|
|
|
Hypertension
10 publications, 0.49%
|
|
|
Inflammopharmacology
10 publications, 0.49%
|
|
|
F1000Research
9 publications, 0.45%
|
|
|
Frontiers in Cardiovascular Medicine
9 publications, 0.45%
|
|
|
Journal of Infection and Public Health
9 publications, 0.45%
|
|
|
Frontiers in Endocrinology
8 publications, 0.4%
|
|
|
The Lancet Respiratory Medicine
8 publications, 0.4%
|
|
|
Medical Hypotheses
8 publications, 0.4%
|
|
|
CKJ: Clinical Kidney Journal
8 publications, 0.4%
|
|
|
Nutrients
7 publications, 0.35%
|
|
|
Biomedicines
7 publications, 0.35%
|
|
|
Healthcare
7 publications, 0.35%
|
|
|
5
10
15
20
25
30
|
Publishers
|
50
100
150
200
250
300
350
400
|
|
|
Elsevier
398 publications, 19.68%
|
|
|
Springer Nature
325 publications, 16.07%
|
|
|
Wiley
147 publications, 7.27%
|
|
|
MDPI
134 publications, 6.63%
|
|
|
Frontiers Media S.A.
132 publications, 6.53%
|
|
|
Cold Spring Harbor Laboratory
115 publications, 5.69%
|
|
|
Taylor & Francis
84 publications, 4.15%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
83 publications, 4.1%
|
|
|
Oxford University Press
55 publications, 2.72%
|
|
|
Public Library of Science (PLoS)
36 publications, 1.78%
|
|
|
Bentham Science Publishers Ltd.
33 publications, 1.63%
|
|
|
BMJ
28 publications, 1.38%
|
|
|
SAGE
24 publications, 1.19%
|
|
|
JMIR Publications
21 publications, 1.04%
|
|
|
Hindawi Limited
20 publications, 0.99%
|
|
|
Medknow
19 publications, 0.94%
|
|
|
Baishideng Publishing Group
16 publications, 0.79%
|
|
|
F1000 Research
11 publications, 0.54%
|
|
|
Mary Ann Liebert
11 publications, 0.54%
|
|
|
American Physiological Society
11 publications, 0.54%
|
|
|
Georg Thieme Verlag KG
10 publications, 0.49%
|
|
|
S. Karger AG
8 publications, 0.4%
|
|
|
Edizioni Minerva Medica
8 publications, 0.4%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
7 publications, 0.35%
|
|
|
Spandidos Publications
6 publications, 0.3%
|
|
|
SciELO
6 publications, 0.3%
|
|
|
The Endocrine Society
5 publications, 0.25%
|
|
|
Massachusetts Medical Society
5 publications, 0.25%
|
|
|
50
100
150
200
250
300
350
400
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2k
Total citations:
2022
Citations from 2024:
108
(5.34%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Fang L. et al. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? // The Lancet Respiratory Medicine. 2020. Vol. 8. No. 4. p. e21.
GOST all authors (up to 50)
Copy
Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? // The Lancet Respiratory Medicine. 2020. Vol. 8. No. 4. p. e21.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/S2213-2600(20)30116-8
UR - https://doi.org/10.1016/S2213-2600(20)30116-8
TI - Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
T2 - The Lancet Respiratory Medicine
AU - Fang, L
AU - Karakiulakis, G.
AU - Roth, M
PY - 2020
DA - 2020/04/01
PB - Elsevier
SP - e21
IS - 4
VL - 8
PMID - 32171062
SN - 2213-2600
SN - 2213-2619
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Fang,
author = {L Fang and G. Karakiulakis and M Roth},
title = {Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?},
journal = {The Lancet Respiratory Medicine},
year = {2020},
volume = {8},
publisher = {Elsevier},
month = {apr},
url = {https://doi.org/10.1016/S2213-2600(20)30116-8},
number = {4},
pages = {e21},
doi = {10.1016/S2213-2600(20)30116-8}
}
Cite this
MLA
Copy
Fang, L., et al. “Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?.” The Lancet Respiratory Medicine, vol. 8, no. 4, Apr. 2020, p. e21. https://doi.org/10.1016/S2213-2600(20)30116-8.